A state-of-the-art review of the recent advances in drug delivery systems for different therapeutic agents in periodontitis.

Autor: Fayazi M; School of Dentistry, Islamic Azad University of Medical Sciences, Tehran, Iran., Rostami M; School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran., Amiri Moghaddam M; Dental Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Nasiri K; Department of Dentistry, Islamic Azad University of Medical Sciences, Tehran, Iran., Tadayonfard A; Department of Prosthodontics, Dental Faculty, Tehran University of Medical Sciences, Tehran, Iran., Roudsari MB; Dental Research Center, Research Institute of Dental Sciences, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Ahmad HM; Pharmacy Department, Al-Noor University College, Nineveh, Iraq., Parhizgar Z; Resident of Periodontology, Department of Periodontics, Mashhad University of Medical Sciences, Mashhad, Iran., Majbouri Yazdi A; School of Dentistry, North Khorasan University of Medical Sciences, Bojnourd, Iran.
Jazyk: angličtina
Zdroj: Journal of drug targeting [J Drug Target] 2024 Dec 27, pp. 1-36. Date of Electronic Publication: 2024 Dec 27.
DOI: 10.1080/1061186X.2024.2445051
Abstrakt: Periodontitis (PD) is a chronic gum illness that may be hard to cure for a number of reasons, including the fact that no one knows what causes it, the side effects of anti-microbial treatment, and how various kinds of bacteria interact with one another. As a result, novel therapeutic approaches for PD treatment must be developed. Additionally, supplementary antibacterial regimens, including local and systemic medication administration of chemical agents, are necessary for deep pockets to assist with mechanical debridement of tooth surfaces. As our knowledge of periodontal disease and drug delivery systems (DDSs) grows, new targeted delivery systems like extracellular vesicles, lipid-based nanoparticles (NPs), metallic NPs, and polymer NPs have been developed. These systems aim to improve the targeting and precision of PD treatments while reducing the systemic side effects of antibiotics. Nanozymes, photodermal therapy, antibacterial metallic NPs, and traditional PD therapies have all been reviewed in this research. Medicinal herbs, antibiotics, photothermal therapy, nanozymes, antibacterial metallic NPs, and conventional therapies for PD have all been examined in this research. After that, we reviewed the key features of many innovative DDSs and how they worked for PD therapy. Finally, we have discussed the advantages and disadvantages of these DDSs.
Databáze: MEDLINE